3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
7
Colonic Neoplasms
6
Recurrence
4
Prostatic Neoplasms
4
Neoplasms
4
Polycythemia Vera
3
Venous Thromboembolism
2
Thrombocythemia, Essential
2
Rectal Neoplasms
2
Myocardial Infarction
2
Esophageal Neoplasms
2
Cardiovascular Diseases
2
Adenoma
2
Vascular Diseases
1
Thrombosis
1
Thrombocytopenia
1
Stomach Neoplasms
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Pathologic Processes
1
Node Positive HER2 Negative Breast Cancer
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Myocardial Ischemia
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lynch syndrome I (site-specific colonic cancer)
1
Lymphoma, Follicular
1
Liver Cirrhosis
1
Ischemic Stroke
1
Interventions
Selenium
4
Epoetin Alfa
3
Vitamin E
2
Darbepoetin alfa
2
Aminolevulinic Acid
2
tirbanibulin
1
human papillomavirus vaccine, L1 type 16, 18
1
ferrous sulfate
1
ferric gluconate
1
alpha-Tocopherol
1
Watchful Waiting
1
Vaginal Smears
1
Toremifene
1
Sulindac
1
Sucrose
1
Soybean Proteins
1
Rosuvastatin Calcium
1
Radiotherapy, Intensity-Modulated
1
Polymerase Chain Reaction
1
Ondansetron
1
Morphine
1
Light Coagulation
1
Imiquimod
1
Hypericum extract LI 160
1
Fenretinide
1
Esomeprazole
1
Eflornithine
1
Early Intervention, Educational
1
Dextromethorphan
1
Deoxyribonuclease (Pyrimidine Dimer)
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Precancerous Conditions
×
Aspirin
×
Clear all
NCT00357682
2025-05-01
AspECT
University of Oxford
Phase 3
Completed
2,557 enrolled
17 charts